Anaphylaxis
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Leaflet PNEUMOVAX 23 solution for injection in pre-filled syringe
- Product code:
- W65876005
- Quantity:
- 1
- Indicated for:
- prevention of pneumococcal disease
- Route of administration:
- injectable
- Substance:
- 23-valent pneumococcal polysaccharide vaccine (vaccine)
- ATC
- J07AL01 — Antiinfectives for systemic use | Bacterial vaccines | Pneumococcal vaccines
Precautions:
Additional monitoring
This medicine is subject to additional monitoring.
Refrigerated storage
Store in the refrigerator as instructed in the leaflet.
Protect from light
Store protected from light.
The 23-valent pneumococcal polysaccharide vaccine (PPSV23) is used to prevent infections caused by Streptococcus pneumoniae, including pneumonia, meningitis, and bacteremia. The vaccine contains purified capsular polysaccharides from 23 different serotypes of the bacterium, which stimulate the immune system to produce specific antibodies against them.
The vaccine is administered intramuscularly or subcutaneously, usually in a single dose, and is recommended for adults over 65 years of age, individuals with chronic illnesses, or those with weakened immune systems. It is also indicated for individuals at increased risk of pneumococcal infections, such as those with chronic lung conditions or diabetes.
Common side effects include pain at the injection site, mild fever, and fatigue. In rare cases, severe allergic reactions may occur.
The 23-valent pneumococcal polysaccharide vaccine is an important preventive measure for reducing the incidence and severity of pneumococcal infections, helping to protect vulnerable populations and reduce mortality associated with these infections.
The vaccine is administered intramuscularly or subcutaneously, usually in a single dose, and is recommended for adults over 65 years of age, individuals with chronic illnesses, or those with weakened immune systems. It is also indicated for individuals at increased risk of pneumococcal infections, such as those with chronic lung conditions or diabetes.
Common side effects include pain at the injection site, mild fever, and fatigue. In rare cases, severe allergic reactions may occur.
The 23-valent pneumococcal polysaccharide vaccine is an important preventive measure for reducing the incidence and severity of pneumococcal infections, helping to protect vulnerable populations and reduce mortality associated with these infections.
General data about PNEUMOVAX 23
- Substance:
- 23-valent pneumococcal polysaccharide vaccine
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W65876005
- Pharmaceutical form:
- solution for injection in pre-filled syringe
- Quantity:
- 1
- Product type:
- Original
- Price:
- 125.40 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Compensation lists for PNEUMOVAX 23 Merck Sharp & Dohme
E2 - Sublist E - section E2 with 100% discount from the reference price
- Price
- 125.40 RON
- Copayment
- 125.40 RON
- Patient
- 0.00 RON